Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-08

Clinical Trial Update: Clinical Trial for Patients With a Stage IV Childhood Renal Tumor, Comparing Upfront Vincristine, Actinomycin-D and Doxorubicin (Standard Arm) With Upfront Vincristine, Carboplatin and Etoposide (Experimental Arm) [Phase 3]

View source ↗

Summary

This Phase 3 trial update outlines a study in stage IV childhood renal tumors comparing upfront vincristine, actinomycin-D, and doxorubicin versus upfront vincr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Actinomycin D (dactinomycin)
  • CARBOPLATIN (Carboplatin)
  • Doxorubicin (doxorubicin)
  • Etoposide (Etoposide)
  • Vincristine (vincristine)

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Childhood Renal Tumor | Phase 3 | Status: RECRUITING